Natixis Advisors
CBST

Natixis Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Natixis Advisors’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,947
Closed -$206K – 1306
2014
Q2 		$206K Buy
+2,947
New +$200K ﹤0.01% 1279
2014
Q1 		– Sell
-3,788
Closed -$261K – 1278
2013
Q4 		$261K Sell
3,788
-345
-8% -$22.3K ﹤0.01% 1051
2013
Q3 		$263K Buy
+4,133
New +$250K ﹤0.01% 1008

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Natixis Advisors's CBST Position: Q3 2014 in Review

Natixis Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2014, closing a stake of 2,947 shares — an estimated $206K sold.

Natixis Advisors first reported a position in CBST in Q3 2013 and held it in 3 quarters. The position peaked at $263K in Q3 2013. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • Natixis Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Natixis Advisors sold 2,947 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $206K.
  • Natixis Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
  • Natixis Advisors's CUBIST PHARMACEUTICALS INC position peaked at $263K in Q3 2013.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on Natixis Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.